EG

Edampadichira Govindan Rajappan

Active Director Designated Partner DIN 11184252
DIN 11184252 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Edampadichira Govindan Rajappan

Data last updated:

Edampadichira Govindan Rajappan is a Designated Partner at Fenzor Life Sciences Llp (since 2025). The company operates in Pharma.

DIN 11184252
Primary Designation Designated Partner
Industry Pharma
First Appointment 04 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Jul 20252025Active

Board colleagues of Edampadichira Govindan Rajappan

NameDINCompanyDesignation
Beegom Fathima11184251Fenzor Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Fenzor Life Sciences Llp
Premium access

Shareholding and investment profile for Edampadichira Govindan Rajappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Edampadichira Govindan Rajappan

Edampadichira Govindan Rajappan currently holds 1 directorship: Fenzor Life Sciences Llp (Designated Partner, since 04 Jul 2025).

Edampadichira Govindan Rajappan was first appointed on 04 Jul 2025 as Designated Partner at Fenzor Life Sciences Llp.

The current boards of Edampadichira Govindan Rajappan's companies include Beegom Fathima (Fenzor Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available